Medpace Holdings, Inc. (MEDP): Price and Financial Metrics
Medpace Holdings, Inc. (MEDP)
Today's Latest Price: $70.50 USD
Updated Apr 2 12:32pm
Add MEDP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 66 in Medical - Services
See all "A" rated Strong Buy stocks
MEDP Stock Summary
- MEDP's went public 3.64 years ago, making it older than just 12% of listed US stocks we're tracking.
- With a year-over-year growth in debt of -43.29%, Medpace Holdings Inc's debt growth rate surpasses only 6.65% of about US stocks.
- As for revenue growth, note that MEDP's revenue has grown 22.19% over the past 12 months; that beats the revenue growth of 78.85% of US companies in our set.
- Stocks that are quantitatively similar to MEDP, based on their financial statements, market capitalization, and price volatility, are ASM, CELH, HMSY, EPAM, and IPI.
- Visit MEDP's SEC page to see the company's official filings. To visit the company's web site, go to www.medpace.com.
MEDP Stock Price Chart More Charts
MEDP Price/Volume Stats
| Current price | $70.50 | 52-week high | $109.09 |
| Prev. close | $68.45 | 52-week low | $52.84 |
| Day low | $67.00 | Volume | 71,320 |
| Day high | $72.27 | Avg. volume | 325,043 |
| 50-day MA | $86.25 | Dividend yield | N/A |
| 200-day MA | $79.06 | Market Cap | 2.57B |
Medpace Holdings, Inc. (MEDP) Company Bio
Medpace, Inc. operates as a contract research organization that provides research based drug and medical device development services. The company was founded in 1992 and is based in Cincinnati, Ohio.
MEDP Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $70.50 | $145.71 | 99% |
Below please find a table outlining a discounted cash flow forecast for MEDP, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Medpace Holdings Inc ranked in the 57th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 99.67%. The most interesting components of our discounted cash flow analysis for Medpace Holdings Inc ended up being:
- Interest coverage, a measure of earnings relative to interest payments, is 80.61; that's higher than 92.35% of US stocks in the Healthcare sector that have positive free cash flow.
- The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than only 6.49% of the free cash flow producing stocks we're observing.
- MEDP's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 61.62% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 95% |
| 1% | 97% |
| 2% | 99% |
| 3% | 101% |
| 4% | 102% |
| 5% | 104% |
Want more companies with a valuation profile/forecast similar to that of Medpace Holdings Inc? See IART, EBS, IONS, UNH, and PDEX.
Loading social stream, please wait...